Abstract |
The arotinoid Ro 15-0778 ( temarotene) is a third generation retinoid without a polar end-group. Established, palpable and measurable rat mammary tumours, chemically induced by oral administration of 12 mg/animal 7,12-dimethylbenz[a] anthracene, were treated with Ro 15-0778 as a feed-admix in daily doses of 100 mg/kg for 6 weeks and 200 and 400 mg/kg for 9 weeks. For comparison, tamoxifen (anti-oestrogen) was administered as a feed-admix in doses of 10 and 30 mg/kg/day for 9 weeks. Treatment with Ro 15-0778 resulted in a marked retardation of tumour growth in the groups treated with 100 and 200 mg/kg/day and in partial or even complete tumour regression in the group receiving 400 mg/kg/day. Tamoxifen treatment caused a transient tumour growth inhibition during weeks 1-5 with subsequent re-growth of mammary tumours. Both compounds were generally well tolerated. No signs or symptoms of hypervitaminosis A were noted with Ro 15-0778. One single convulsive attack occurred with 200 mg/kg/day of Ro 15-0778 and 400 mg/kg/day caused occasional convulsions in five out of 11 rats. The present investigation underlines the fact that the arotinoid Ro 15-0778 is not only a chemopreventive agent but also exerts a chemotherapeutic effect on established, chemically induced, mammary carcinomas of the rat.
|
Authors | K Teelmann, W Bollag |
Journal | European journal of cancer & clinical oncology
(Eur J Cancer Clin Oncol)
Vol. 24
Issue 7
Pg. 1205-9
(Jul 1988)
ISSN: 0277-5379 [Print] England |
PMID | 3138121
(Publication Type: Journal Article)
|
Chemical References |
- Retinoids
- Tamoxifen
- 9,10-Dimethyl-1,2-benzanthracene
- temarotene
|
Topics |
- 9,10-Dimethyl-1,2-benzanthracene
- Animals
- Female
- Mammary Neoplasms, Experimental
(chemically induced, drug therapy)
- Rats
- Rats, Inbred Strains
- Retinoids
(therapeutic use)
- Tamoxifen
(therapeutic use)
|